Viewing Study NCT06545305


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-01-09 @ 3:00 AM
Study NCT ID: NCT06545305
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-08-13
First Post: 2024-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Incidence and Risk Factors of Ocular Complications Among Patients With Homocystinuria
Sponsor: King Fahad Armed Forces Hospital
Organization:

Study Overview

Official Title: Incidence and Risk Factors of Ocular Complications Among Patients With Homocystinuria in Jeddah, Saudi Arabia: A Cross-sectional Study
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background: Cysteine beta-synthase (CBS) deficiency, often known as classic homocystinuria (HCU), is an uncommon inborn mistake in methionine metabolism. Developmental delay, intellectual incapacity, skeletal and vascular symptoms, and ocular abnormalities are possible main clinical characteristics.

Objective: This study sought to describe the ocular anomalies that King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia, HCU patients presented with between 2018 and 2022.
Detailed Description: This retrospective research included 6 HCU patients. Demographic and clinical characteristics of patients as age, gender, comorbidities were collected. Relevant clinical and ophthalmic assessments, like visual acuity, fundus examination findings, complications and type of surgery were also reported

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
King Fahd Armed Forces OTHER REC 607 View